Lifastuzumab, CAS [[1615697-16-9]]

Produktübersicht

• Artikelname: Lifastuzumab, CAS [[1615697-16-9]]
• Artikelnummer: MCE-HY-P99970
• Hersteller Artikelnummer: HY-P99970
• Alternativnummer: MCE-HY-P99970-10MG,MCE-HY-P99970-5MG,MCE-HY-P99970-1MG
• Hersteller: MedchemExpress
• Kategorie: Antikörper

Produktbeschreibung

Lifastuzumab is a humanized anti-NaPi2b IgG1 monoclonal antibody. Lifastuzumab can be coupled with monomethyl auristatin E (MMAE) (HY-15162) through ADC Linker to form an antibody-drug conjugate (ADC) Lifastuzumab vedotin (HY-P99705) with anticancer activity. Lifastuzumab vedotin can be studied in research for non-small cell lung cancer and ovarian cancer. Recommend Isotype Control: Human IgG1 kappa, Isotype Control (HY-P99001)[1][2].

Produkteigenschaften

• Molekulargewicht: (145.66 kDa)
• Reinheit: 99.08
• CAS Nummer: [1615697-16-9]
• Target-Kategorie: ADC Antibody,Sodium Phosphate Cotransporter

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Inhibitory Antibodies